Home > Press > NN-Labs Receives $2 million in SBIR Contracts
NN-Labs Receives $2 million in SBIR Contracts
Fayetteville, AR | Posted on October 17, 2006
NN-Labs, LLC (Nanomaterials and Nanofabrication Laboratories), an Arkansas based nanotechnology firm, was recently awarded three Small Business Innovation Research (SBIR) contracts. The awards consist of two Phase II contracts, from the National Institutes of Health (NIH) and the National Science Foundation (NSF), and one Phase I contract from NIH; all three contracts total $1.8 million. Work on these new projects is already underway.
The funds will aid in NN-Labs’ ability to extend its strength in nanocrystals into end products in the biomedical field. Currently, cadmium containing semiconductor nanocrystals constitute all of the company’s standardized product lines for semiconductor nanocrystals, also known as quantum dots. While non-cadmium containing nanomaterials, such as gold nanoparticles and iron oxide (Fe3O4) magnetic Nanoparticles, are available through custom orders, the product lines are not yet complete or standardized.
The NIH Phase II, entitled Kits for Converting Nanocrystals to Standard Bio-Medical Reagents, Second Generation Nanocrystal Bio-Medical Labels follows the success of the Phase I that focused on the development of bio-medical labels based on the first generation of semiconductor nanocrystals, CdSe quantum dots. NN-Labs will develop the second generation of quantum dots, which are doped zinc containing semiconductor nanocrystals (d-dots). D-dots will ultimately remove heavy metal cadmium from the current workhorse—cadmium selenide related nanocrystals—of quantum dots. In addition, d-dots are also more durable and have better optical properties when high density emitters are needed. It is expected that these new fluorescence labels will make early diagnosis of various diseases and pathogens more practical and less expensive.
Commercial Scale Production of High Quality and Affordable Fe3O4 Nanocrystals for Nano-Biomedicine is the title of the NSF Phase II contract that will expand upon the product line developed in the Phase I contract. The biomedical applications for these Fe3O4 magnetic nanocrystals cover many aspects of the biomedical field, ranging from diagnostics, detection, therapy, separation, and pollution control, etc, which is at least a multi-billion-dollar market. Yet another variety of nanocrystal is to be developed with funding from the NIH Phase I contract, entitled High Yield and Inexpensive Production of High Quality Gold Nanocrystals as Bio-Labels. Similar to the other contracts, the end goal is to enhance already existing biomedical techniques as well as open the door to novel applications in the biomedical field. NN-Labs strives to complete this Phase I as successfully as we have for other Phase I awards, which will help us to secure the corresponding Phase II award from NIH with additional funding of $750K for two years.
NN-Labs has been business active for about four years, since July of 2002. The company has received 15 SBIR contracts (about $5m in total) that have partially funded the development of four standardized product lines, with several other product lines that are still under development and in the trial sales stage. The company maintains affiliations with the University of Arkansas and the Arkansas Science and Technology Authority (ASTA). NN-Labs is also a member of the Genesis Technology Incubator. Additional information about NN-Labs can be found on the company’s website, www.nn-labs.com, or by contacting Leah Sheridan at 479-575-2723 or firstname.lastname@example.org.
Copyright © NN-Labs, LLC
If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 August 12th, 2014
Aspen Aerogels, Inc. to Present at Canaccord Genuity 34th Annual Growth Conference August 11th, 2014
Nanoscale assembly line August 29th, 2014
Copper shines as flexible conductor August 29th, 2014
Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices August 28th, 2014
PetLife Comments on CNN Story on Scorpion Venom Health Benefits August 27th, 2014
Fonon Announces 3D Metal Sintering Technology: Emerging Additive Nano Powder Manufacturing Technology August 28th, 2014
SouthWest NanoTechnologies CEO Dave Arthur to Discuss “Carbon Nanotubes and Automotive Applications” at The Automotive Composites Conference and Expo 2014 (ACCE2014) August 28th, 2014
Nanodiamonds Are Forever: A UCSB professor’s research examines 13,000-year-old nanodiamonds from multiple locations across three continents August 27th, 2014
Competition for Graphene: Berkeley Lab Researchers Demonstrate Ultrafast Charge Transfer in New Family of 2D Semiconductors August 26th, 2014
Raman Whispering Gallery Detects Nanoparticles September 1st, 2014
Nanoscale assembly line August 29th, 2014
New analytical technology reveals 'nanomechanical' surface traits August 29th, 2014
New Vice President Takes Helm at CNSE CMOST: Catherine Gilbert To Lead CNSE Children’s Museum of Science and Technology Through Expansion And Relocation August 29th, 2014